Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Mark G. Davies, M.D., Ph.D.

Mark G. Davies, M.D., Ph.D.


Mark G. Davies, M.D., Ph.D.

Mark G. Davies, M.D., Ph.D.

Senior Member
The Methodist Hospital Research Institute
Professor of Surgery and Vice Chairman
Department of Cardiovascular Surgery
Methodist DeBakey Heart & Vascular Center 
The Methodist Hospital 

E-mail: mdavies@houstonmethodist.org
Phone: 713-441-5200
Fax: 713-790-3058


M.B.A (Executive) William E. Simon Graduate School of Business University of Rochester Rochester, NY
Ph.D. Trinity College, Dublin, Ireland

Postdoctoral Training

Residency, Vascular Surgery University of Washington Seattle, WA
Residency, General Surgery Duke University Durham, NC
Residency, General Surgery Royal College of Surgeons in Ireland Dublin, Ireland



Dr. Mark Davies Is Professor and Vice Chairman in the Department of Cardiovascular Surgery, Methodist Heart and Vascular Center at The Methodist Hospital/Weill Cornell Medical College of Cornell University. Prior to joining the faculty at Methodist in 2008, he held assistant and associate professorships in Vascular Surgery at the University of Rochester in Rochester, New York. He is the recipient of many awards including the United States National Institutes of Health Cardiovascular Research Training Program Fellowship and the Lifeline Foundation Research Award. Dr. Davies is active in cardiovascular research, including several past and present NIH-sponsored studies, and has a particular interest in gene therapy studies. He is certified by the American Board of Surgery, ARDMS, the Royal College of Physicians of Ireland, The Royal College of Surgeons of Ireland and the Royal College of Surgeons of England.

Description of Research

Dr. Davies’ research interests include the signal biology of phospholipids, protease biology, metabolic syndrome, outcomes of endovascular surgery and clinical gene and molecular therapy.

Major Areas of Research

Phospholipids and Protease Biology
Biology of Metabolic Syndrome
Outcomes Research in Vascular Surgery
Clinical Gene and Molecular Therapy

Recent Publications

Duru EA, Fu Y, Davies MG. Src Regulates Sphingosine-1-Phosphate Mediated Smooth Muscle Cell Migration. J Surg Res. 2011 Aug 10. PMID: 21920544

Lumsden AB, Anaya-Ayala JE, Birnbaum I, Davies MG, Bismuth J, Cheema ZF, El Sayed HF, Seethamraju H, Loebe M, Valderrabano M. Robot-assisted stenting of a high-grade anastomotic pulmonary artery stenosis following single lung transplantation. J Endovasc Ther. 2010 Oct;17(5):612-6

Bellows PH, Anaya-Ayala JE, Cheema ZF, Davies MG, Lumsden AB, Peden EK. Combined Femoral Vein Transposition and Iliac Vein to Suprarenal Vena Cava Bypass as a Last Resort Dialysis Access. Ann Vasc Surg. 2010 Aug 26

Bellows PH, Anaya-Ayala JE, Younes HK, Charlton-Ouw KM, Bismuth J, Davies MG, Peden EK. Spontaneous regression of an abdominal aortic aneurysm in an immunocompromised patient. Vasc Med. 2010 Aug;15(4):315-9

Bismuth J, Donovan MA, O'Malley MK, El Sayed HF, Naoum JJ, Peden EK, Davies MG, Lumsden AB. Incorporating simulation in vascular surgery education. J Vasc Surg. 2010 Oct;52(4):1072-80.

Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB. Outcomes of interventions for recurrent disease after endoluminal intervention for superficial femoral artery disease.J Vasc Surg. 2010 Aug;52(2):331-9.e1-2.

Karmonik C, Bismuth J, Davies MG, Lumsden AB. Computational fluid dynamics as a tool for visualizing hemodynamic flow patterns. Methodist Debakey Cardiovasc J. 2009;5(3):26-33

Protack CD, Saad WA, Davies MG. Renal artery interventions during infrarenal endovascular aortic repair: a greater potential of subsequent failure? J Vasc Interv Radiol. 2010 Apr;21(4):459-64

Kaiser CL, Anaya-Ayala JE, Ismail N, Davies MG, Peden EK. Unrecognized basilic vein variation leading to complication during basilic vein transposition arteriovenous fistula creation: case report and implications for access planning. Eur J Vasc Endovasc Surg. 2010 May;39(5):627-9.

Davies MG, Bismuth J. Arteriovenous malformations--diagnosis and treatment. Methodist Debakey Cardiovasc J. 2009;5(4):41-5.

Reardon MJ, Davies MG. Central venous stenosis--endovascular and surgical treatments. Methodist Debakey Cardiovasc J. 2009;5(4):32-5.

Davies MG. Deep venous thrombosis: prevention and treatment. Methodist Debakey Cardiovasc J. 2009;5(4):25-31

Davies MG. Overview of venous disease. Methodist Debakey Cardiovasc J. 2009;5(4):5-6.

Davies MG, Saad WE, Bismuth J, Naoum JJ, Peden EK, Lumsden AB. Renal parenchymal preservation after percutaneous renal angioplasty and stenting. J Vasc Surg. 2010 May;51(5):1222-9; discussion 1229.

Younes HK, Harris PW, Bismuth J, Charlton-Ouw K, Peden EK, Lumsden AB, Davies MG. Thoracic endovascular aortic repair for type B aortic dissection. Ann Vasc Surg. 2010 Jan;24(1):39-43.

Davies MG, Saad WE, Bismuth J, Naoum JJ, Peden EK, Lumsden AB. Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting. J Vasc Surg. 2010 Apr;51(4):926-32.

Karmonik C, Bismuth J, Davies MG, Younes HK, Lumsden AB. An image processing algorithm for the in-vivo quantification and visualization of septum motion in type III B - aortic dissections with cine magnetic resonance imaging. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:4391-4.

Younes HK, Davies MG, Bismuth J, Naoum JJ, Peden EK, Reardon MJ, Lumsden AB. Hybrid thoracic endovascular aortic repair: pushing the envelope. J Vasc Surg. 2010 Jan;51(1):259-66. Epub 2009 Dec 2.

Davies MG, Bismuth J, Saad WE, Naoum JJ, Mohiuddin IT, Peden EK, Lumsden AB. Implications of in situ thrombosis and distal embolization during superficial femoral artery endoluminal intervention. Ann Vasc Surg. 2010 Jan;24(1):14-22.

Lumsden AB, Davies MG, Peden EK. Medical and endovascular management of critical limb ischemia. J Endovasc Ther. 2009 Apr;16(2 Suppl 2):II31-62.

Bakken AM, Protack CD, Roztocil E, Nicholl SM, Davies MG. Cell migration in response to the amino-terminal fragment of urokinase requires epidermal growth factor receptor activation through an ADAM-mediated mechanism. J Vasc Surg. 2009 May;49(5):1296-303.

Protack CD, Bakken AM, Xu J, Saad WA, Lumsden AB, Davies MG. Metabolic syndrome: A predictor of adverse outcomes after carotid revascularization. J Vasc Surg. 2009 May;49(5):1172-80.e1

Davies MG, Saad WA, Bismuth JX, Peden EK, Naoum JJ, Lumsden AB. Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting. J Vasc Surg. 2009 Apr;49(4):946-52.

Davies MG, Saad WE, Bismuth JX, Naoum JJ, Peden EK, Lumsden AB. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney. J Vasc Surg. 2009 Apr;49(4):953-60.

Garami ZF, Bismuth J, Charlton-Ouw KM, Davies MG, Peden EK, Lumsden AB. Feasibility of simultaneous pre- and postfilter transcranial Doppler monitoring during carotid artery stenting. J Vasc Surg. 2009 Feb;49(2):340-4, 345.e1-2; discussion 345.